Literature DB >> 16466971

Novel lethal mouse mutants produced in balancer chromosome screens.

Kathryn E Hentges1, Hisashi Nakamura, Yasuhide Furuta, Yuejin Yu, Debrah M Thompson, William O'Brien, Allan Bradley, Monica J Justice.   

Abstract

Mutagenesis screens are a valuable method to identify genes that are required for normal development. Previous mouse mutagenesis screens for lethal mutations were targeted at specific time points or for developmental processes. Here we present the results of lethal mutant isolation from two mutagenesis screens that use balancer chromosomes. One screen was localized to mouse chromosome 4, between the STS markers D4Mit281 and D4Mit51. The second screen covered the region between Trp53 and Wnt3 on mouse chromosome 11. These screens identified all lethal mutations in the balancer regions, without bias towards any phenotype or stage of death. We have isolated 19 lethal lines on mouse chromosome 4, and 59 lethal lines on chromosome 11, many of which are distinct from previous mutants that map to these regions of the genome. We have characterized the mutant lines to determine the time of death, and performed a pair-wise complementation cross to determine if the mutations are allelic. Our data suggest that the majority of mouse lethal mutations die during mid-gestation, after uterine implantation, with a variety of defects in gastrulation, heart, neural tube, vascular, or placental development. This initial group of mutants provides a functional annotation of mouse chromosomes 4 and 11, and indicates that many novel developmental phenotypes can be quickly isolated in defined genomic intervals through balancer chromosome mutagenesis screens.

Entities:  

Mesh:

Year:  2006        PMID: 16466971     DOI: 10.1016/j.modgep.2005.11.015

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  22 in total

1.  Novel mutations in Lrp6 orthologs in mouse and human neural tube defects affect a highly dosage-sensitive Wnt non-canonical planar cell polarity pathway.

Authors:  Redouane Allache; Stéphanie Lachance; Marie Claude Guyot; Patrizia De Marco; Elisa Merello; Monica J Justice; Valeria Capra; Zoha Kibar
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

2.  Mesenchymal expression of the FRAS1/FREM2 gene unit is decreased in the developing fetal diaphragm of nitrofen-induced congenital diaphragmatic hernia.

Authors:  Toshiaki Takahashi; Florian Friedmacher; Julia Zimmer; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-10-30       Impact factor: 1.827

Review 3.  Optical Coherence Tomography for live imaging of mammalian development.

Authors:  Irina V Larina; Kirill V Larin; Monica J Justice; Mary E Dickinson
Journal:  Curr Opin Genet Dev       Date:  2011-09-29       Impact factor: 5.578

4.  Deficiency of FRAS1-related extracellular matrix 1 (FREM1) causes congenital diaphragmatic hernia in humans and mice.

Authors:  Tyler F Beck; Danielle Veenma; Oleg A Shchelochkov; Zhiyin Yu; Bum Jun Kim; Hitisha P Zaveri; Yolande van Bever; Sunju Choi; Hannie Douben; Terry K Bertin; Pragna I Patel; Brendan Lee; Dick Tibboel; Annelies de Klein; David W Stockton; Monica J Justice; Daryl A Scott
Journal:  Hum Mol Genet       Date:  2012-12-05       Impact factor: 6.150

5.  A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.

Authors:  Aleata A Triplett; Cristina Montagna; Kay-Uwe Wagner
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 6.  Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy.

Authors:  Darlene S Douglas; Brian Popko
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

7.  The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia.

Authors:  Valerie K Jordan; Tyler F Beck; Andres Hernandez-Garcia; Peter N Kundert; Bum-Jun Kim; Shalini N Jhangiani; Tomasz Gambin; Molly Starkovich; Jaya Punetha; Ingrid S Paine; Jennifer E Posey; Alexander H Li; Donna Muzny; Chih-Wei Hsu; Amber J Lashua; Xin Sun; Caraciolo J Fernandes; Mary E Dickinson; Kevin P Lally; Richard A Gibbs; Eric Boerwinkle; James R Lupski; Daryl A Scott
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

8.  A mouse chromosome 4 balancer ENU-mutagenesis screen isolates eleven lethal lines.

Authors:  Melissa K Boles; Bonney M Wilkinson; Andrea Maxwell; Lihua Lai; Alea A Mills; Ichiko Nishijima; Andrew P Salinger; Ivan Moskowitz; Karen K Hirschi; Bin Liu; Allan Bradley; Monica J Justice
Journal:  BMC Genet       Date:  2009-03-06       Impact factor: 2.797

9.  Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxin.

Authors:  Melissa K Boles; Bonney M Wilkinson; Laurens G Wilming; Bin Liu; Frank J Probst; Jennifer Harrow; Darren Grafham; Kathryn E Hentges; Lanette P Woodward; Andrea Maxwell; Karen Mitchell; Michael D Risley; Randy Johnson; Karen Hirschi; James R Lupski; Yosuke Funato; Hiroaki Miki; Pablo Marin-Garcia; Lucy Matthews; Alison J Coffey; Anne Parker; Tim J Hubbard; Jane Rogers; Allan Bradley; David J Adams; Monica J Justice
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

10.  Correlation of microsynteny conservation and disease gene distribution in mammalian genomes.

Authors:  Simon C Lovell; Xiting Li; Nimmi R Weerasinghe; Kathryn E Hentges
Journal:  BMC Genomics       Date:  2009-11-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.